Search research articles
Contact Us
Filters
Showing results (91-100 of 133) with videos related to
Page
of 14
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Oncoimmunology
|
November 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanoma
Michael G White, Robert Szczepaniak Sloane, Russell G Witt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial
Ethan B Ludmir, Alexander D Sherry, Bryan M Fellman, et al.
JCO Clinical Cancer Informatics
|
August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set
Stephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
European Urology
|
August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial
Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Oncoimmunology
|
May 4, 2016
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
Zachary A Cooper, Alexandre Reuben, Christine N Spencer, et al.
Nature Communications
|
June 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing
Yi Han, Yuqiu Yang, James Zhu, et al.
JAMA Oncology
|
April 29, 2016
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
Guo Chen, Jennifer L McQuade, David J Panka, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 25, 2026
Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure
Bo Zhu, Muhammad Aminu, Pingjun Chen, et al.
Cancer Discovery
|
July 23, 2017
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence
Alexandre Reuben, Rachel Gittelman, Jianjun Gao, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 133) with videos related to
Sort By:
Page
of 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Oncoimmunology
|
November 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanoma
Michael G White, Robert Szczepaniak Sloane, Russell G Witt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial
Ethan B Ludmir, Alexander D Sherry, Bryan M Fellman, et al.
JCO Clinical Cancer Informatics
|
August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set
Stephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
European Urology
|
August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial
Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Oncoimmunology
|
May 4, 2016
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
Zachary A Cooper, Alexandre Reuben, Christine N Spencer, et al.
Nature Communications
|
June 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing
Yi Han, Yuqiu Yang, James Zhu, et al.
JAMA Oncology
|
April 29, 2016
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
Guo Chen, Jennifer L McQuade, David J Panka, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 25, 2026
Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure
Bo Zhu, Muhammad Aminu, Pingjun Chen, et al.
Cancer Discovery
|
July 23, 2017
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence
Alexandre Reuben, Rachel Gittelman, Jianjun Gao, et al.
Page
of 14